Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414148
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-04-29
Brief Title:
MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
Sponsor:
Peter MacCallum Cancer Centre Australia
Organization:
Peter MacCallum Cancer Centre Australia
Organization Data
Organization:
Peter MacCallum Cancer Centre Australia
Class:
OTHER
Study ID:
22012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peter MacCallum Cancer Centre Australia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AbbVie | INDUSTRY |